On Mar 10, 2022 FluoGuide closed a Post-IPO Equity round and raised SEK250,000,000 from investors, featuring lead investors .

About the company: FluoGuide is located at Denmark, Europe.
“FluoGuide A/S is a clinical stage biotechnology company focused on developing drugs for maximizing surgical outcomes by making cancer fluorescent.”

Company website: http://www.fluoguide.com